SK Biopharmaceuticals and Arvelle Therapeutics Announce Agreement to Develop and Commercialize Cenobamate in Europe
Arvelle Therapeutics to receiv…
The Art & Science of Wellness
Arvelle Therapeutics to receiv…
SINGAPORE, Feb. 13, 2019 /PRNe…
SEONGNAM, South Korea, Feb. 11…
SHENYANG, China and BOSTON, Fe…
Medical imaging’s critic…
BANGKOK, Thailand, Feb. 7, 201…
-New partner ecosystem enables…
SINGAPORE, Feb. 7, 2019 /PRNew…
多語言WordPress ,採用WPML